Rallis India Ltd
Rallis India, a Tata Group company Group Co., has a history of over 150 years. The company is into manufacturing of Agrochemicals and is present across the value chain of agriculture inputs - from seeds to organic plant growth nutrients. Rallis is also in the business of contract manufacturing for global corporations. [1]
- Market Cap ₹ 4,575 Cr.
- Current Price ₹ 236
- High / Low ₹ 386 / 196
- Stock P/E 29.0
- Book Value ₹ 87.2
- Dividend Yield 1.06 %
- ROCE 12.8 %
- ROE 9.61 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 29.1%
Cons
- The company has delivered a poor sales growth of 9.38% over past five years.
- Company has a low return on equity of 12.1% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,068 | 1,245 | 1,423 | 1,693 | 1,738 | 1,529 | 1,664 | 1,791 | 1,984 | 2,252 | 2,429 | 2,604 | |
| 873 | 1,039 | 1,211 | 1,429 | 1,458 | 1,298 | 1,397 | 1,524 | 1,740 | 1,989 | 2,105 | 2,323 | |
| Operating Profit | 194 | 206 | 213 | 264 | 280 | 231 | 266 | 267 | 244 | 263 | 325 | 281 |
| OPM % | 18% | 17% | 15% | 16% | 16% | 15% | 16% | 15% | 12% | 12% | 13% | 11% |
| 14 | -10 | 12 | 6 | 3 | 14 | 170 | 13 | 30 | 46 | 49 | 22 | |
| Interest | 7 | 17 | 21 | 15 | 12 | 16 | 9 | 7 | 8 | 10 | 7 | 7 |
| Depreciation | 17 | 29 | 32 | 41 | 50 | 44 | 48 | 46 | 46 | 62 | 64 | 74 |
| Profit before tax | 184 | 149 | 172 | 214 | 222 | 186 | 380 | 227 | 220 | 237 | 304 | 222 |
| Tax % | 31% | 33% | 31% | 29% | 28% | 21% | 22% | 26% | 30% | 23% | 25% | 26% |
| 126 | 101 | 119 | 153 | 157 | 147 | 297 | 167 | 155 | 184 | 229 | 164 | |
| EPS in Rs | 6.48 | 5.10 | 6.12 | 7.81 | 8.08 | 7.37 | 15.30 | 8.62 | 7.99 | 9.50 | 11.75 | 8.44 |
| Dividend Payout % | 31% | 43% | 38% | 31% | 31% | 34% | 25% | 29% | 31% | 26% | 26% | 36% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -2% |
| 3 Years: | 1% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -4% |
| 3 Years: | 1% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 485 | 534 | 601 | 699 | 795 | 869 | 1,092 | 1,171 | 1,266 | 1,390 | 1,571 | 1,677 |
| 117 | 154 | 131 | 77 | 125 | 90 | 39 | 25 | 73 | 94 | 76 | 93 | |
| 395 | 414 | 438 | 502 | 496 | 506 | 559 | 763 | 804 | 945 | 922 | 1,069 | |
| Total Liabilities | 1,017 | 1,121 | 1,190 | 1,297 | 1,436 | 1,484 | 1,709 | 1,978 | 2,163 | 2,448 | 2,589 | 2,858 |
| 348 | 517 | 555 | 604 | 595 | 564 | 574 | 574 | 581 | 593 | 631 | 771 | |
| CWIP | 159 | 60 | 35 | 21 | 26 | 40 | 42 | 47 | 51 | 76 | 164 | 130 |
| Investments | 26 | 23 | 20 | 25 | 24 | 28 | 239 | 96 | 109 | 302 | 283 | 212 |
| 484 | 522 | 580 | 647 | 790 | 851 | 854 | 1,261 | 1,422 | 1,477 | 1,510 | 1,745 | |
| Total Assets | 1,017 | 1,121 | 1,190 | 1,297 | 1,436 | 1,484 | 1,709 | 1,978 | 2,163 | 2,448 | 2,589 | 2,858 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88 | 94 | 145 | 176 | 68 | 232 | 408 | 41 | 80 | 337 | 217 | 166 | |
| -134 | -74 | -40 | -76 | -54 | -147 | -289 | 89 | -51 | -246 | -161 | -104 | |
| 46 | -24 | -90 | -119 | -17 | -59 | -80 | -104 | -52 | -74 | -67 | -61 | |
| Net Cash Flow | 0 | -4 | 15 | -19 | -2 | 26 | 39 | 26 | -23 | 17 | -12 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 30 | 42 | 36 | 52 | 54 | 58 | 81 | 83 | 73 | 61 | 63 |
| Inventory Days | 141 | 143 | 111 | 119 | 146 | 171 | 166 | 224 | 224 | 193 | 200 | 227 |
| Days Payable | 165 | 130 | 104 | 110 | 107 | 116 | 139 | 206 | 178 | 176 | 156 | 182 |
| Cash Conversion Cycle | 12 | 43 | 49 | 45 | 91 | 109 | 86 | 100 | 129 | 90 | 105 | 107 |
| Working Capital Days | -13 | -5 | -11 | 8 | 31 | 43 | 45 | 80 | 82 | 50 | 61 | 62 |
| ROCE % | 36% | 27% | 25% | 29% | 27% | 21% | 22% | 20% | 18% | 16% | 18% | 13% |
Documents
Announcements
-
Audio Recording Of Analysts/Investors Call Pertaining To The Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025
4h - Audio recording of analysts/investors call on Q3 and 9M FY26 results held Jan 21, 2026.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
23h - Investor Presentation for analysts/investors on the unaudited financial results for the third quarter and nine months ended December 31, 2025 for the analysts/investors call to …
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
24h - Q3 FY26 revenue ₹623 crore (+19%); Q3 PAT ₹2 crore; 9M revenue ₹2,441 crore (+9%).
-
Board Meeting Outcome for Board Meeting Outcome For January 20, 2026
1d - Approved Q3 and nine-months ended Dec 31, 2025 results: revenue Q3 ₹623cr, nine months ₹2,441cr; net profit nine months ₹199cr.
- Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2025 1d
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
Oct 2025Transcript PPT
-
Jul 2025Transcript PPT
-
Apr 2025Transcript PPT REC
-
Feb 2025TranscriptAI SummaryPPT
-
Jan 2025TranscriptPPT
-
Jan 2025Transcript PPT REC
-
Oct 2024Transcript PPT REC
-
Jul 2024Transcript PPT
-
Apr 2024Transcript PPT REC
-
Jan 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Oct 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Apr 2022TranscriptPPT
-
Apr 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Jul 2021TranscriptAI SummaryPPT
-
Apr 2021Transcript PPT
-
Jan 2021TranscriptAI SummaryPPT
-
Oct 2020TranscriptAI SummaryPPT
-
Jul 2020Transcript PPT
-
May 2020Transcript PPT
-
Jan 2020Transcript PPT
-
Oct 2019TranscriptAI SummaryPPT
-
Jul 2019TranscriptAI SummaryPPT
-
Jan 2019TranscriptAI SummaryPPT
-
Oct 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Apr 2017TranscriptAI SummaryPPT
-
Jan 2017TranscriptAI SummaryPPT
-
Apr 2016TranscriptAI SummaryPPT
Business Overview[1]
Company is part of the Tata group, one of the leading players in the domestic crop protection sector and manufactures insecticides, herbicides, and fungicides at its factories. These agrochemicals are sold in 80% of India’s districts through an extensive distribution network. The Rallis Innovation Chemistry Hub (RICH) caters to domestic and global requirements.